肺叶切除时机对临床IA期肺鳞癌生存的影响
本研究基于美国国家癌症数据库(2006-2011)4,984例临床IA期肺鳞癌患者,评估诊断至肺叶切除时间与生存的关系。多变量分析显示,诊断后38天及以上手术者5年生存显著更差(HR 1.13,95%CI 1.02-1.25;结论认为延长诊断至手术间隔与更差生存相关。
要点
- 临床IA期肺鳞癌诊断后38天及以上行肺叶切除与更差5年生存相关。
- 限制性立方样条分析提示延迟约90天或以上与生存显著恶化相关。
- 在完成必要术前评估的前提下,应尽量减少不必要的治疗延迟。
核心结论
- 早期肺鳞癌诊断至肺叶切除间隔延长与更差生存相关。
- 减少超出完整术前评估所需的延迟可能改善生存。
研究设计与样本
- 基于美国国家癌症数据库(2006-2011)的回顾性队列分析。
- 纳入4,984例符合研究标准的临床IA期肺鳞癌患者。
- 采用多变量Cox比例风险分析和限制性立方样条函数评估手术时机与生存的关系。
主要发现
- 4,984例患者5年总生存率为58.3%(95%CI 56.3-60.2)。
- 1,811例(36%)患者在诊断后30天内手术,中位手术时间为38天(四分位距23-58)。
- 限制性立方样条分析显示手术时间相关风险比随延迟延长而稳步升高,与生存显著恶化相关的阈值约为90天或以上。
临床怎么用
- 对临床IA期肺鳞癌患者,在完成完整术前评估后应尽量缩短诊断至肺叶切除的间隔。
- 避免因非必要原因将手术延迟至约90天或以上。
局限性
- 除治疗时机外其他因素也可能 contribute 于该发现。
- 研究为回顾性数据库分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Because the relationship between the timing of surgery following diagnosis of lung cancer and survival has not been precisely described, guidelines on what constitutes a clinically meaningful delay of resection of early-stage lung cancer do not exist. This study tested the hypothesis that increasing the time between diagnosis and lobectomy for stage IA squamous cell carcinoma (SCC) would be associated with worse survival. METHODS: The association between timing of lobectomy and survival for patients with clinical stage IA SCC in the National Cancer Data Base (2006-2011) was assessed using multivariable Cox proportional hazards analysis and restricted cubic spline (RCS) functions. RESULTS: The 5-year overall survival of 4,984 patients who met study inclusion criteria was 58.3% (95% CI, 56.3-60.2). Surgery was performed within 30 days of diagnosis in 1,811 (36%) patients, whereas the median time to surgery was 38 days (interquartile range, 23, 58). In multivariable analysis, patients who had surgery 38 days or more after diagnosis had significantly worse 5-year survival than patients who had surgery earlier (hazard ratio, 1.13 [95% CI, 1.02-1.25]; P = .022). Multivariable RCS analysis demonstrated the hazard ratio associated with time to surgery increased steadily the longer resection was delayed; the threshold time associated with statistically significant worse survival was ∼90 days or greater. CONCLUSIONS: Longer intervals between diagnosis of early-stage lung SCC and surgery are associated with worse survival. Although factors other than the timing of treatment may contribute to this finding, these results suggest that efforts to minimize delays beyond those needed to perform a complete preoperative evaluation may improve survival.
引用
- Yang CJ, Wang H, Kumar A, et al. Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. Chest. 2017. PMID: 28800867. doi:10.1016/j.chest.2017.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。